Pacer Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Pacer Advisors's HALO Position: Q1 2026 in Review
Pacer Advisors reduced its Halozyme (HALO) stake by 68% in Q1 2026, selling an estimated $45.2M and leaving 295,524 shares worth $19.1M. The position accounts for 0.05% of the portfolio, ranked #316.
Pacer Advisors first reported a position in HALO in Q4 2017 and has held it in 23 quarters since. The position peaked at $63.1M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Pacer Advisors held 295,524 shares of Halozyme worth $19.1M as of Q1 2026.
- Pacer Advisors sold 641,769 Halozyme shares in Q1 2026, an estimated $45.2M.
- Halozyme made up 0.05% of Pacer Advisors's portfolio in Q1 2026, its #316 holding.
- Pacer Advisors first reported a position in Halozyme in Q4 2017 and has held it in 23 quarters since.
- Pacer Advisors's Halozyme position peaked at $63.1M in Q4 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.